Abstract
Throughout 2021, the medical and scientific communities have focused on managing the acute morbidity and mortality caused by the coronavirus disease 2019 (COVID-19) pandemic. With the approval of multiple vaccines, there is a light at the end of this dark tunnel and an opportunity to focus on the future, including managing the long-term sequelae in patients who have survived acute COVID-19. In this Perspectives article, we highlight what is known about the cardiovascular sequelae in survivors of COVID-19 and discuss important questions that need to be addressed in prospective studies to understand and mitigate these lasting cardiovascular consequences, including in post-acute COVID-19 syndrome. To provide the greatest benefit to these survivors, prospective studies should begin now, with resources made available to monitor and study this population in the coming years.
【초록키워드】 COVID-19, coronavirus disease, pandemic, Vaccines, Prospective Study, Consequences, Survivors, Patient, morbidity and mortality, Scientific community, resource, syndrome, approval, acute COVID-19, MONITOR, survivor, mitigate, benefit, highlight, caused, question, addressed, survived, 【제목키워드】 COVID-19, cardiac, implication,